>
Switch to:

Can Fite Biofarma Debt-to-Equity

: 0.01 (As of Dec. 2020)
View and export this data going back to 2012. Start your Free Trial

Can Fite Biofarma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $0.04 Mil. Can Fite Biofarma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $0.02 Mil. Can Fite Biofarma's Total Stockholders Equity for the quarter that ended in Dec. 2020 was $6.07 Mil. Can Fite Biofarma's debt to equity for the quarter that ended in Dec. 2020 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

AMEX:CANF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.02   Max: 0.03
Current: 0.01

0.01
0.03

During the past 11 years, the highest Debt-to-Equity Ratio of Can Fite Biofarma was 0.03. The lowest was 0.01. And the median was 0.02.

AMEX:CANF's Debt-to-Equity is ranked higher than
87% of the 1083 Companies
in the Biotechnology industry.

( Industry Median: 0.08 vs. AMEX:CANF: 0.01 )

Can Fite Biofarma Debt-to-Equity Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can Fite Biofarma Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.03 0.01

Can Fite Biofarma Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 0.01 0.01 0.01

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Can Fite Biofarma Debt-to-Equity Distribution

* The bar in red indicates where Can Fite Biofarma's Debt-to-Equity falls into.



Can Fite Biofarma Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Can Fite Biofarma's Debt to Equity Ratio for the fiscal year that ended in Dec. 2020 is calculated as

Can Fite Biofarma's Debt to Equity Ratio for the quarter that ended in Dec. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Can Fite Biofarma  (AMEX:CANF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Can Fite Biofarma Debt-to-Equity Related Terms


Can Fite Biofarma Debt-to-Equity Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)